| 000 | 01714 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517144309.0 | ||
| 264 | 0 | _c20170503 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1678-9849 | ||
| 024 | 7 |
_a10.1590/0037-8682-0455-2016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBorges, Myrlena Mescouto | |
| 245 | 0 | 0 |
_aEfficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil. _h[electronic resource] |
| 260 |
_bRevista da Sociedade Brasileira de Medicina Tropical _c |
||
| 300 |
_a67-74 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAmphotericin B _xadverse effects |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDeoxycholic Acid _xadverse effects |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeishmaniasis, Visceral _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeglumine _xadverse effects |
| 650 | 0 | 4 | _aMeglumine Antimoniate |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xadverse effects |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPranchevicius, Maria Cristina da Silva | |
| 700 | 1 | _aNoronha, Elza Ferreira | |
| 700 | 1 | _aRomero, Gustavo Adolfo Sierra | |
| 700 | 1 | _aCarranza-Tamayo, César Omar | |
| 773 | 0 |
_tRevista da Sociedade Brasileira de Medicina Tropical _gvol. 50 _gno. 1 _gp. 67-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1590/0037-8682-0455-2016 _zAvailable from publisher's website |
| 999 |
_c27001595 _d27001595 |
||